(Q39459903)

12 September 2017

1 reference

title

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic (English)

1 reference

12 September 2017

1 reference

K L Goa

1

1 reference

PubMed ID

2874976

12 September 2017

A Ward

series ordinal

2

1 reference

12 September 2017

1 August 1986

1 reference

12 September 2017

1 reference

12 September 2017

32

1 reference

12 September 2017

114-129

1 reference

12 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198632020-00002

12 September 2017

0 references

cites work

Neuroendocrine effects of buspirone in patients with generalized anxiety disorder

1 reference

12 December 2020

Double-blind comparison of buspirone and clorazepate in anxious outpatients

1 reference

12 December 2020

Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5HT neurons.

1 reference

12 December 2020

Intravenous buspirone self-administration in rhesus monkeys

1 reference

12 December 2020

Buspirone and diazepam in anxiety: a controlled study

1 reference

12 December 2020

Effects of long-term administration of buspirone and diazepam on driver steering control.

1 reference

12 December 2020

Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.

1 reference

12 December 2020

Anxiety in primary care: Is short-term drug treatment appropriate?

1 reference

12 December 2020

Autoradiographic localization of [3H]buspirone binding sites in rat brain

1 reference

12 December 2020

Buspirone: Action on serotonin receptors in calf hippocampus

1 reference

12 December 2020

Preclinical pharmacology of buspirone hydrochloride

1 reference

12 December 2020

Comparison of buspirone in two separate studies

1 reference

12 December 2020

Capillary gas chromatographic-mass spectrometric determination of buspirone in plasma

1 reference

12 December 2020

Assessment of the abuse liability of buspirone in recreational sedative users

1 reference

12 December 2020

Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.

1 reference

12 December 2020

Buspirone: review of its pharmacology and current perspectives on its mechanism of action

1 reference

12 December 2020

Effects of alcohol on buspirone and lorazepam actions

1 reference

12 December 2020

Comparison of buspirone and diazepam in generalized anxiety disorder.

1 reference

12 December 2020

Notes on buspirone's mechanisms of action.

1 reference

12 December 2020

Pharmacology and neurochemistry of buspirone

1 reference

12 December 2020

The relationship between buspirone bioavailability and dose in healthy subjects

1 reference

12 December 2020

Dopamine receptor antagonism by the novel antianxiety drug, buspirone

1 reference

12 December 2020

Monoaminergic involvement in the pharmacological actions of buspirone

1 reference

12 December 2020

Effects of buspirone on conflict behavior of laboratory rats and monkeys

1 reference

12 December 2020

Neuropharmacology of Buspirone

1 reference

12 December 2020

Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug

1 reference

12 December 2020

Comparative Effects of Diazepam and Buspirone on Subjective Feelings, Psychological Tests and the EEG

1 reference

12 December 2020

Clinical profile of buspirone

1 reference

12 December 2020

Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro[4.5]decane-7,9-diones

1 reference

12 December 2020

Buspirone increases locus coeruleus noradrenergic neuronal activity in vitro.

1 reference

12 December 2020

Buspirone: A potential atypical neuroleptic

1 reference

12 December 2020

The effect of buspirone on prolactin and growth hormone secretion in man

1 reference

12 December 2020

Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity

1 reference

12 December 2020

Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex

1 reference

12 December 2020

Review of the side-effect profile of buspirone

1 reference

12 December 2020

Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain

1 reference

12 December 2020

The comparative efficacy of buspirone and diazepam in the treatment of anxiety

1 reference

12 December 2020

Buspirone: multicenter efficacy study

1 reference

12 December 2020

A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder

1 reference

12 December 2020

Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties.

1 reference

12 December 2020

Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use

1 reference

12 December 2020

An interim multicentre report on 677 anxious geriatric out-patients treated with buspirone

1 reference

12 December 2020

Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover

1 reference

12 December 2020

Discriminative stimulus properties of buspirone compared to central nervous system depressants in rats.

1 reference

12 December 2020

Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission

1 reference

12 December 2020

"Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic"

1 reference

12 December 2020

Assessment of addiction liability of benzodiazepines and buspirone.

1 reference

12 December 2020

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG

1 reference

12 December 2020

The risk of pharmacological dependence with buspirone.

1 reference

12 December 2020

Buspirone enhances [3H]flunitrazepam binding in vivo

1 reference

12 December 2020

Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings

1 reference

12 December 2020

The psychological effects of buspirone

1 reference

12 December 2020

Investigation of the abuse liability of buspirone in alcohol-dependent patients.

1 reference

12 December 2020

Metabolism and disposition of buspirone

1 reference

12 December 2020

Pharmacologic effects of MJ 9022-1, a potential tranquilizing agent

1 reference

12 December 2020

Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study

1 reference

12 December 2020

Buspirone: an anxiolytic without sedative effect.

1 reference

12 December 2020

Dopaminergic effects of buspirone, a novel anxiolytic agent

1 reference

12 December 2020

1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.

1 reference

12 December 2020

MJ 9022: correlation between neuroleptic potential and stereotypy

1 reference

12 December 2020

Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat

1 reference

12 December 2020

The non-benzodiazepine anxiolytic buspirone inhibits stress-induced renin secretion and lowers heart rate

1 reference

12 December 2020

Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system

1 reference

12 December 2020

The effects of buspirone, BMY-13805 and 1-(2-pyrimidinyl)-piperazine on cat spinal reflexes

1 reference

12 December 2020

Effects of chronically administered buspirone and diazepam on driving-related skills performance

1 reference

12 December 2020

Buspirone: anxiolytic?

1 reference

12 December 2020

The side effect profile of buspirone in comparison to active controls and placebo

1 reference

12 December 2020

10.2165/00003495-198632020-00002

Identifiers

DOI

1 reference

PubMed ID

2874976

Dimensions Publication ID

12 September 2017

0 references

1 reference

PubMed ID

2874976